Journal Information
Statistics
Follow this link to access the full text of the article
Editorial
SGLT2 inhibitors after acute heart failure: Great benefit, low prescription rates
iSGLT2 tras insuficiencia cardiaca aguda: mucho beneficio, poca prescripción